Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aura Biosciences, Inc. Director's Dealing 2021

Oct 28, 2021

33080_dirs_2021-10-28_18ddd4c3-934a-46e8-ba2b-f3d911b0aa1f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aura Biosciences, Inc. (AURA)
CIK: 0001501796
Period of Report: 2021-10-28

Reporting Person: Mariggi Giovanni (Director)